Golden Biotechnology (4132)

Currency in TWD
12.05
+0.65(+5.70%)
Closed·

4132 Financial Summary

Key Ratios

P/E Ratio-5.45
Price/Book6.92
Debt / Equity120.15%
Return on Equity-101.91%
Dividend Yield0.00%
EBITDA-329.94M
Fair ValueUnlock
Fair Value UpsideUnlock

Statements Highlights

Period Ending:
2015
31/12
2016
31/12
2017
31/12
2018
31/12
2019
31/12
2020
31/12
2021
31/12
2022
31/12
2023
31/12
2024
31/12
* In Millions of TWD (except for per share items)

Earnings

Latest Release
Apr 25, 2025
EPS / Forecast
-1.26 / --
Revenue / Forecast
17.97M / --
EPS Revisions
Last 90 days

FAQ

What were Golden BioTech's earnings for the latest quarter?

The Golden BioTech EPS (TTM) is -2.39. Golden BioTech reported sales of 17.97, net income of -199.90, and EPS of -1.26 for the latest quarter.

What was Golden BioTech's net income for the latest quarter?

Golden BioTech's net income for the latest quarter was -199.90.

How did Golden BioTech's performance compare year-over-year in the latest quarter?

The company's revenue moved from 22.95 in the previous quarter to 17.97 in the latest quarter, and net income moved from -160.80 to -199.90 compared to the previous quarter.

What is Golden BioTech's net profit margin on a TTM basis?

Golden BioTech's trailing twelve months (TTM) net profit margin is -881.51%.

How does Golden BioTech's debt to equity ratio compare to industry standards?

Golden BioTech's total debt-to-equity ratio is 120.15%.

What is Golden BioTech's return on investment on a TTM basis?

Golden BioTech's trailing twelve months (TTM) return on investment (ROI) is -101.91%.

Did Golden BioTech gain or lose cash last quarter?

In the latest quarter, Golden BioTech's net change in cash was 129.49 million.

What were Golden BioTech's total assets and liabilities in the latest quarter?

As of the latest quarter, Golden BioTech reported total assets of 722.30 million and total liabilities of 345.05 million.

How has Golden BioTech's total revenue grown this year?

Golden BioTech's total revenue was 22.95 in the previous quarter and 17.97 in the latest quarter.

What is Golden BioTech's gross margin on a TTM basis?

Golden BioTech's trailing twelve months (TTM) gross margin is -17.14%.

What was Golden BioTech's revenue per share for the latest quarter?

Golden BioTech's revenue per share for the latest quarter was 3.67.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.